We're almost flying blind wrt CPACS. Keen to know what role Dent (and Brian Jensen?) may play going forward. Just some of the other CPACS updates I'm hanging out for:
Doan et al 2.0
MOA(s) publication
Further work from Erin Howden
Surprising lack of cardiotoxicity at Sheba 2.0
P1a/b Trial design and strategy
We're almost flying blind wrt CPACS. Keen to know what role Dent...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.000(0.00%) |
Mkt cap ! $212.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20000 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 10000 | 1 |
View Market Depth
| Last trade - 08.10am 26/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |
Day chart unavailable